Discovery of a Potent PLK1-PBD Small-Molecule Inhibitor as an Anticancer Drug Candidate Through Structure-Based Design

Molecules- Switzerland

doi 10.3390/molecules24234351

Full Text

Abstract

Available in

Date

Authors

Publisher

MDPI AG

Related search

Discovery of Potent Anticancer Agent HJC0416, an Orally Bioavailable Small Molecule Inhibitor of Signal Transducer and Activator of Transcription 3 (STAT3)

European Journal of Medicinal Chemistry
MedicineOrganic ChemistryDrug DiscoveryPharmacology
2014English

Structure Based Discovery of Clomifene as a Potent Inhibitor of Cancer-Associated Mutant IDH1

Oncotarget
Oncology
2017English

Structure-Based DNA-Targeting Strategies With Small Molecule Ligands for Drug Discovery

Medicinal Research Reviews
Drug DiscoveryMolecular MedicinePharmacology
2013English

Systems-Based Discovery of Tomatidine as a Natural Small Molecule Inhibitor of Skeletal Muscle Atrophy

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2014English

Discovery of Small Molecule Integrin Avb3 Antagonists as Novel Anticancer Agents

English

Discovery of Indole Tetrafluorophenoxymethylketone-Based Potent Novel Small Molecule Inhibitors of Caspase-3

Organic and Medicinal Chemistry Letters
2012English

Anticancer Drug Discovery — From Serendipity to Rational Design

2013English

Discovery of SCY45, a Natural Small‐Molecule MDM2‐p53 Interaction Inhibitor.

Chemistry and Biodiversity
Molecular MedicineMolecular BiologyBiochemistryMedicineBioengineeringChemistry
2019English

Small Molecule PROTACs: An Emerging Technology for Targeted Therapy in Drug Discovery

RSC Advances
ChemistryChemical Engineering
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy